Ivo Nnane

1.3k total citations
46 papers, 1.0k citations indexed

About

Ivo Nnane is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Ivo Nnane has authored 46 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 11 papers in Pharmacology. Recurrent topics in Ivo Nnane's work include Prostate Cancer Treatment and Research (12 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Hormonal and reproductive studies (9 papers). Ivo Nnane is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Hormonal and reproductive studies (9 papers). Ivo Nnane collaborates with scholars based in United States, Belgium and United Kingdom. Ivo Nnane's co-authors include Vincent C.O. Njar, Brian J. Long, Dmitry N. Grigoryev, Angela Brodie, Katsuya Kato, Ge Lin, L. A. Damani, B. Dasgupta, Xie L. Xu and Miao Ye and has published in prestigious journals such as Blood, Hepatology and Endocrinology.

In The Last Decade

Ivo Nnane

46 papers receiving 975 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivo Nnane United States 17 359 252 186 171 168 46 1.0k
Araba A. Adjei United States 19 616 1.7× 214 0.8× 96 0.5× 335 2.0× 209 1.2× 32 1.3k
Xin Dong China 21 549 1.5× 195 0.8× 88 0.5× 78 0.5× 70 0.4× 68 1.3k
Heather K. Webb United States 18 678 1.9× 102 0.4× 265 1.4× 114 0.7× 261 1.6× 23 1.8k
Maria R. De Miglio Italy 25 1.1k 3.2× 182 0.7× 64 0.3× 147 0.9× 71 0.4× 77 1.8k
Jisong Cui United States 21 559 1.6× 137 0.5× 246 1.3× 237 1.4× 172 1.0× 27 2.2k
Akiko Ando Japan 19 695 1.9× 128 0.5× 40 0.2× 345 2.0× 100 0.6× 41 1.4k
Rick E.W. van Leeuwen Netherlands 19 780 2.2× 76 0.3× 106 0.6× 62 0.4× 60 0.4× 24 1.5k
Takafumi Nishimura Japan 21 823 2.3× 269 1.1× 97 0.5× 102 0.6× 55 0.3× 51 1.8k
Maria M. Simile Italy 27 1.5k 4.1× 118 0.5× 72 0.4× 150 0.9× 83 0.5× 59 2.2k
Rong Bu Saudi Arabia 26 718 2.0× 129 0.5× 104 0.6× 181 1.1× 22 0.1× 61 1.5k

Countries citing papers authored by Ivo Nnane

Since Specialization
Citations

This map shows the geographic impact of Ivo Nnane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivo Nnane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivo Nnane more than expected).

Fields of papers citing papers by Ivo Nnane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivo Nnane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivo Nnane. The network helps show where Ivo Nnane may publish in the future.

Co-authorship network of co-authors of Ivo Nnane

This figure shows the co-authorship network connecting the top 25 collaborators of Ivo Nnane. A scholar is included among the top collaborators of Ivo Nnane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivo Nnane. Ivo Nnane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Man, Peijuan Zhu, Ivo Nnane, et al.. (2021). Population Pharmacokinetics and Exposure‐Response Modeling of Daratumumab Subcutaneous Administration in Patients With Light‐Chain Amyloidosis. The Journal of Clinical Pharmacology. 62(5). 656–669. 8 indexed citations
2.
Xu, Xu Steven, Philippe Moreau, Saad Z. Usmani, et al.. (2020). Split First Dose Administration of Intravenous Daratumumab for the Treatment of Multiple Myeloma (MM): Clinical and Population Pharmacokinetic Analyses. Advances in Therapy. 37(4). 1464–1478. 9 indexed citations
3.
Smolen, Josef S, Sandeep K. Agarwal, Е. П. Иливанова, et al.. (2017). A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate. Annals of the Rheumatic Diseases. 76(5). 831–839. 113 indexed citations
4.
5.
Raghu, Ganesh, Fernando J. Martínez, Kevin K. Brown, et al.. (2015). CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab. European Respiratory Journal. 46(6). 1740–1750. 101 indexed citations
6.
Brodie, A., et al.. (2006). The effect of tamoxifen on the pharmacokinetics of letrozole in female rats. Biopharmaceutics & Drug Disposition. 27(7). 335–344. 3 indexed citations
7.
Wu, Chunyu, Vincent C.O. Njar, Angela Brodie, Michael Borenstein, & Ivo Nnane. (2004). Quantification of a novel retinoic acid metabolism inhibitor, 4-(1H-imidazol-1-yl)retinoic acid (VN/14-1RA) and other retinoids in rat plasma by liquid chromatography with diode-array detection. Journal of Chromatography B. 810(2). 203–208. 7 indexed citations
8.
Handratta, Venkatesh, Danijela Jelovac, Brian J. Long, et al.. (2004). Potent CYP17 inhibitors: improved syntheses, pharmacokinetics and anti-tumor activity in the LNCaP human prostate cancer model. The Journal of Steroid Biochemistry and Molecular Biology. 92(3). 155–165. 19 indexed citations
9.
10.
11.
Nnane, Ivo, et al.. (2002). HPLC analysis of 4-chlorophenyl methyl sulphide and diphenyl sulphide and their corresponding sulphoxides and sulphones in rat liver microsomes. Journal of Pharmaceutical and Biomedical Analysis. 27(1-2). 315–325. 14 indexed citations
12.
Nnane, Ivo, et al.. (2001). Pharmacokinetic profile of 3β-hydroxy-17-(1H-1,2,3-triazol-1-yl)androsta-5,16-diene (VN/87-1), a potent androgen synthesis inhibitor, in mice. The Journal of Steroid Biochemistry and Molecular Biology. 78(3). 241–246. 7 indexed citations
13.
Njar, Vincent C.O., Ivo Nnane, & Angela Brodie. (2000). Potent inhibition of retinoic acid metabolism enzyme(s) by novel azolyl retinoids. Bioorganic & Medicinal Chemistry Letters. 10(17). 1905–1908. 20 indexed citations
14.
15.
Nnane, Ivo, Vincent C.O. Njar, Yen‐Chin Liu, Qing‐Bin Lu, & A. Brodie. (1999). Effects of novel 17-azolyl compounds on androgen synthesis in vitro and in vivo. The Journal of Steroid Biochemistry and Molecular Biology. 71(3-4). 145–152. 18 indexed citations
16.
17.
Nnane, Ivo & L. A. Damani. (1999). Metabolism of ethyl methyl sulphide and sulphoxide in rat microsomal fractions. Xenobiotica. 29(11). 1101–1113. 7 indexed citations
18.
Kato, Katsuya, Liu Yang, Xin Wang, et al.. (1998). Synthesis and in vitro activity of some epimeric 20α-hydroxy, 20-oxime and aziridine pregnene derivatives as inhibitors of human 17α-hydroxylase/c17,20-lyase and 5α-reductase. Bioorganic & Medicinal Chemistry. 6(10). 1683–1693. 31 indexed citations
19.
Lin, Ge, et al.. (1998). High performance liquid chromatographic analysis of a novel aminoalkylpyridine anticonvulsant 2-(4-chlorophenyl)amino-2-(4-pyridyl)ethane. Journal of Pharmaceutical and Biomedical Analysis. 18(3). 403–409. 1 indexed citations
20.
Damani, L. A. & Ivo Nnane. (1996). The Assessment of Flavin-Containing Monooxygenase Activity in Intact Animals. Drug metabolism and drug interactions. 13(1). 1–28. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Araba A. Adjei Breakdown of academic impact, for papers by Xin Dong Breakdown of academic impact, for papers by Heather K. Webb Breakdown of academic impact, for papers by Maria R. De Miglio Breakdown of academic impact, for papers by Jisong Cui Breakdown of academic impact, for papers by Akiko Ando Breakdown of academic impact, for papers by Rick E.W. van Leeuwen Breakdown of academic impact, for papers by Takafumi Nishimura Breakdown of academic impact, for papers by Maria M. Simile Breakdown of academic impact, for papers by Rong Bu
Rankless by CCL
2026